Last reviewed · How we verify

Anestan — Competitive Intelligence Brief

Anestan (HALOTHANE) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: halothane. Area: Neuroscience.

marketed halothane GABA-A receptor; anion channel Neuroscience Small molecule Live · refreshed every 30 min

Target snapshot

Anestan (HALOTHANE).

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Anestan TARGET HALOTHANE marketed halothane GABA-A receptor; anion channel 1958-01-01
Suprane DESFLURANE Baxter marketed General Anesthetic [EPC] GABA-A receptor; anion channel 1992-01-01
Metabarbital METHARBITAL AbbVie marketed metharbital GABA-A receptor; anion channel 1982-01-01
Trichlophos TRICLOFOS Sanofi marketed triclofos GABA-A receptor; anion channel 1982-01-01
Paxipam HALAZEPAM Merck & Co. marketed halazepam GABA-A receptor; anion channel 1981-01-01
Klonopin clonazepam Generic (originally Roche) marketed Benzodiazepine [EPC] GABA-A receptor alpha-1/beta-2/gamma-2, GABA-A receptor; anion channel, GABA-A receptor; anion channel 1975-06-04
Metofane METHOXYFLURANE Abbott marketed methoxyflurane Glycine receptor subunit alpha-1, GABA-A receptor; anion channel

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (halothane class)

  1. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Anestan — Competitive Intelligence Brief. https://druglandscape.com/ci/halothane. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: